Publication | Closed Access
Effective therapeutic measures for reducing lipoprotein (A) in patients with dyslipidemia: Lipoprotein (A) reduction with sustained-release bezafibrate
34
Citations
0
References
1991
Year
Metabolic SyndromeLipid DisorderCardiovascular DiseaseDiabetesPharmacologySustained-release BezafibrateEffective Therapeutic MeasuresHyperlipidemiaLipoprotein MetabolismMedicineAtherosclerosisDyslipidemia
No additional data available for this publication yet. Check back later!